Industry: Pharmaceuticals, Biotechnology
GlobeImmune is a biopharmaceutical company pioneering the discovery, development and manufacturing of potent, targeted molecular immunotherapy products called Tarmogens for the treatment of cancer and infectious diseases. The Company’s lead product, GI-5005, a Tarmogen for the treatment of chronic hepatitis C infection is currently in a placebo-controlled, Phase 1b human clinical trial. GI-4000, a Tarmogen for the treatment of various Ras-mediated cancers, is in a randomized, placebo-controlled, multi-center Phase 2 trial for the treatment of patients with early-stage pancreas cancer. ( www.globeimmune.com )
GlobeImmune , Inc.
12635 E. Montview Blvd.
Aurora, Colorado 80010
USA
Tel: (720) 859-4070
Fax: (720) 859-4065